Acute sporadic non-A, non-B, non-C, non-D, non-E hepatitis

Hepatology

Volumn 25, Issue 2, 1997, Pages 478-483

  Rochling, Fedja A ^a   Jones, Whitney F ^a   Chau, Kurt ^b   DuCharme, Louise ^b   Mimms, Larry T ^b   Moore, Bonnie ^b   Scheffel, James ^b   Cuthbert, Jennifer A ^a   Thiele, Dwain L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL FEATURE; FEMALE; HEPATITIS C; HEPATITIS NON A NON B; HUMAN; INCIDENCE; JAUNDICE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; VIRUS HEPATITIS;

EID: 0031032715     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250237     Document Type: Article

References (38)

1. Prince AM, Brotman B, Grady GF, Kuhns WJ, Hazzi C, Levine RW, Millian SJ. Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet 1974;ii:241-246.
2. Dienstag JL. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 1983;85:439-462.
3. Williams R, Wendon J. Indications for orthotopic liver transplantation in fulminant liver failure. HEPATOLOGY 1994;20(suppl):5S-10S.
4. Dodson SF, Dehara K, Iwatsuki S. Liver transplantation for fulminant hepatic failure. ASAIO J 1994;40:86-88.
5. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PYH, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-1905.
6. Krawczynski K. Hepatitis E. HEPATOLOGY 1993;17:932-941.
7. Alter HJ. Descartes before the horse: I clone, therefore I am: The hepatitis C virus in current perspective. Ann Intern Med 1991;115:644-649.
8. Wright TL, Hsu H, Donegan E, Feinstone S, Greenberg H, Read A, Ascher NL, et al. Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med 1991;115:111-112.
9. Theilmann L, Solbach C, Toex U, Müller HM, Pfaff E, Otto G, et al. Role of hepatitis C virus infection in German patients with fulminant and subacute hepatic failure. Eur J Clin Invest 1992;22:569-571.
10. Feray C, Gigou M, Samuel D, Reyes G, Bernuau J, Reynes M, et al. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 1993;104:549-555.
11. Liang TJ, Jeffers L, Reddy RK, Silva MO, Cheinquer H, Findor A, DeMedina M, et al. Fulminant or subfulminant non-A, non-B viral hepatitis: The role of hepatitis C and E viruses. Gastroenterology 1993; 104: 556-562.
12. Sallie R, Silva AE, Purdy M, Smith H, McCaustland K, Tibbs C, et al. Hepatitis C and E in non-A, non-B fulminant hepatic failure: A polymerase chain reaction and serological study. J Hepatol 1994;20:580-588.
13. Kuwada SK, Patel VM, Hollinger FB, Lin HJ, Yarbough PO, Wiesner RH, et al. Non-A, non-B fulminant hepatitis is also non-E and non-C. Am J Gastroenterol 1994;89:57-61.
14. Hibbs JR, Frickhofer N, Rosenfeld SJ, Feinstone SM, Kojima S, Bacigalupo A, et al. Aplastic anemia and viral hepatitis. Non-A, non-B, non-C? JAMA 1992;267:2051-2054.
15. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995;1:564-569.
16. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, et al. Sequence and genomic organization of GBV-C - A novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996;48:60-67.
17. Linnen J, Wages J Jr, Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 1996;271:505-508.
18. Liaw YF, Yang CY, Chu CM, Huang MJ. Appearance and persistence of hepatitis A IgM antibody in acute clinical hepatitis A observed in an outbreak. Infection 1986;14:156-158.
19. Chau KH, Hargie MP, Decker RH, Mushahwar IK, Overby LR. Serodiagnosis of recent hepatitis B infection by IgM class anti-HBc. HEPATOLOGY 1983;3:142-149.
20. Thiele DL, DuCharme L, Cunningham MR, Mimms LT, Cuthbert JA, et al. Steroid therapy of chronic hepatitis: Characteristics associated with response in anti-hepatitis C virus-positive and -negative patients. Am J Gastroenterol 1996;91:300-308.
21. Vallari DS, Jett BW, Alter HJ, Mimms LT, Holzman R, Shih JW-K. Serological markers of posttransfusion hepatitis C viral infection. J Clin Microbiol 1992;30:552-556.
22. Zaaijer HL, Vallari DS, Cunningham M, Lesniewski R, Reesink HW, van der Poel CL, et al. E2 and NS5: New antigens for detection of hepatitis C virus antibodies. J Med Virol 1994;44:395-397.
23. Dawson GJ, Chau KH, Cabal CM, Yarbough PO, Reyes GR, Mushahwar IK. Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J Virol Methods 1992;38:175-186.
24. Young KKY, Resnick RM, Myers TW. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol 1993;31:882-886.
25. Han JH, Shyamala V, Richman MJ, Brauer MJ, Irvine B, Urdea MS, et al. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5′ untranslated region and poly(A) tails at the 3′ end. Proc Natl Acad Sci U S A 1991;88:1711-1715.
26. Puoti M, Zonaro A, Ravaggi A, Marin MG, Castelnuovo F, Cariani E. Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection. HEPATOLOGY 1992;16:877-881.
27. Fong T-L, Valinluck B, Govindarajan S, Rolon N, Lee SR, Page E, et al. Marked improvement in sensitivity of second-generation tests for acute hepatitis C virus infection. J Infect Dis 1993;168:519-520.
28. McNeil M, Hoy JF, Richards MJ, Lehmann NI, Dimitrikakis M, Gust ID, Lucas CR. Aetiology of fatal viral hepatitis in Melbourne. A retrospective study. Med J Aust 1984;141:637-640.
29. Tassapoulos NC, Hatzakis A, Delladetsima I, Koutelou MG, Todoulos A, Miriagou V. Role of hepatitis C virus in acute non-A, non-B hepatitis in Greece: A 5 year prospective study. Gastroenterology 1992; 102:969-972.
30. Tassopoulos NC, Krawczynski K, Hatzakis A, Katsoulidou A, Delladetsima I, Koutelou MG, et al. Case Report: Role of hepatitis E virus in the etiology of community-acquired non-A, non-B hepatitis in Greece. J Med Virol 1994; 42:124-128.
31. Gimson AES, O'Grady J, Ede RJ, Portmann B, Williams R. Late onset hepatic failure: Clinical, serological and histological features. HEPATOLOGY 1986;6:288-294.
32. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273-275.
33. Wright TL, Mamish D, Combs C, Kim M, Donegan E, Ferrell L, et al. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet 1992;339:952-955.
34. Thiers V, Lunel F, Valla D, Azar N, Fretz C, Frangeul L, et al. Posttransfusional anti-HCV-negative non-A, non-B hepatitis (II) serological and polymerase chain reaction analysis for hepatitis C and hepatitis B viruses. J Hepatol 1993;18:34-39.
35. Dawson GJ, Schlauder GS, Pilot-Matias TJ, Thiele D, Leary TP, Murphy P, Rosenblatt JE, et al. Prevalence studies of GB virus-C infection using reverse-transcriptase-polymerase chain reaction. J Med Virol 1996; 50:97-103.
36. Lefkowitch JH, Apfelbaum TF, Weinberg L, Forester G. Acute liver biopsy lesions in early autoimmune ("lupoid") chronic active hepatitis. Liver 1984; 4:379-386.
37. McFarlane IG. Autoimmunity and hepatotropic viruses. Semin Liv Dis 1991;11:223-233.
38. Niwa Y, Sakane T, Kanoh T, Shichijo S, Wiederhold MD, Yokoyama MM. Transient autoantibodies with elevated complement levels in common viral diseases. J Clin Lab Immunol 1984;13:183-188.